These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23626603)

  • 1. Does L-carnitine improve endothelial function in hemodialysis patients?
    Sabri MR; Fahimi F; Hajialiasgar S; Etminan A; Nazemi S; Salehi F
    J Res Med Sci; 2012 May; 17(5):417-21. PubMed ID: 23626603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of oral L-carnitine therapy in chronic hemodialysis patients.
    Sabry AA
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):454-9. PubMed ID: 20427868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-carnitine treatment in incident hemodialysis patients: the multicenter, randomized, double-blinded, placebo-controlled CARNIDIAL trial.
    Mercadal L; Coudert M; Vassault A; Pieroni L; Debure A; Ouziala M; Depreneuf H; Fumeron C; Servais A; Bassilios N; Bécart J; Assogba U; Allouache M; Bouali B; Luong N; Dousseaux MP; Tezenas-du Montcel S; Deray G
    Clin J Am Soc Nephrol; 2012 Nov; 7(11):1836-42. PubMed ID: 22935844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects.
    Ahmad S; Robertson HT; Golper TA; Wolfson M; Kurtin P; Katz LA; Hirschberg R; Nicora R; Ashbrook DW; Kopple JD
    Kidney Int; 1990 Nov; 38(5):912-8. PubMed ID: 2266675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic stabilizing effects of L-carnitine in chronic hemodialysis patients.
    Kudoh Y; Aoyama S; Torii T; Chen Q; Nagahara D; Sakata H; Nozawa A
    Cardiorenal Med; 2013 Oct; 3(3):200-207. PubMed ID: 24454315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can L-Carnitine Supplementation Improve Cardiopulmonary Function? A Randomized Controlled Clinical Trial in Hemodialysis Patients.
    Yassari F; Dastan F; Marashian SM; Eslaminejad A; Maleki Kazeri F
    Iran J Kidney Dis; 2020 Dec; 14(6):494-499. PubMed ID: 33277455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of levocarnitine on brachial-ankle pulse wave velocity in hemodialysis patients: a randomized controlled trial.
    Higuchi T; Abe M; Yamazaki T; Mizuno M; Okawa E; Ando H; Oikawa O; Okada K; Kikuchi F; Soma M
    Nutrients; 2014 Dec; 6(12):5992-6004. PubMed ID: 25533009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of L-carnitine therapy on respiratory function tests in chronic hemodialysis patients.
    Bavbek N; Akay H; Uz B; Uz E; Turgut F; Kanbay M; Senes M; Akcay A; Duranay M
    Ren Fail; 2010 Jan; 32(2):157-61. PubMed ID: 20199175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of L-carnitine on leukocyte function and viability in hemodialysis patients: A double-blind randomized trial.
    Thomas S; Fischer FP; Mettang T; Pauli-Magnus C; Weber J; Kuhlmann U
    Am J Kidney Dis; 1999 Oct; 34(4):678-87. PubMed ID: 10516349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of l-carnitine supplement on serum amyloid A and vascular inflammation markers in hemodialysis patients: a randomized controlled trial.
    Tabibi H; Hakeshzadeh F; Hedayati M; Malakoutian T
    J Ren Nutr; 2011 Nov; 21(6):485-91. PubMed ID: 21439850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Oral L-Carnitine Supplementation on Lipid Profile, Anemia, and Quality of Life in Chronic Renal Disease Patients under Hemodialysis: A Randomized, Double-Blinded, Placebo-Controlled Trial.
    Emami Naini A; Moradi M; Mortazavi M; Amini Harandi A; Hadizadeh M; Shirani F; Basir Ghafoori H; Emami Naini P
    J Nutr Metab; 2012; 2012():510483. PubMed ID: 22720143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients.
    Brass EP; Adler S; Sietsema KE; Hiatt WR; Orlando AM; Amato A;
    Am J Kidney Dis; 2001 May; 37(5):1018-28. PubMed ID: 11325685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective Effects of L-Carnitine Against Delayed Graft Function in Kidney Transplant Recipients: A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.
    Jafari A; Khatami MR; Dashti-Khavidaki S; Lessan-Pezeshki M; Abdollahi A; Moghaddas A
    J Ren Nutr; 2017 Mar; 27(2):113-126. PubMed ID: 28065453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life during and between hemodialysis treatments: role of L-carnitine supplementation.
    Sloan RS; Kastan B; Rice SI; Sallee CW; Yuenger NJ; Smith B; Ward RA; Brier ME; Golper TA
    Am J Kidney Dis; 1998 Aug; 32(2):265-72. PubMed ID: 9708611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the efficacy of captopril, simvastatin, and L-carnitine as cardioprotective drugs in children with type 1 diabetes mellitus: a randomised controlled trial.
    Badreldeen A; El Razaky O; Erfan A; El-Bendary A; El Amrousy D
    Cardiol Young; 2021 Aug; 31(8):1315-1322. PubMed ID: 33536102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of L-carnitine supplementation on lipid parameters in hemodialysis patients.
    Elisaf M; Bairaktari E; Katopodis K; Pappas M; Sferopoulos G; Tzallas C; Tsolas O; Siamopoulos KC
    Am J Nephrol; 1998; 18(5):416-21. PubMed ID: 9730566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Unexpected Effects of L-Carnitine Supplementation on Lipid Metabolism in Hemodialysis Patients.
    Katalinic L; Krtalic B; Jelakovic B; Basic-Jukic N
    Kidney Blood Press Res; 2018; 43(4):1113-1120. PubMed ID: 30016788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oral L-carnitine on serum myoglobin in hemodialysis patients.
    Feinfeld DA; Kurian P; Cheng JT; Dilimetin G; Arriola MR; Ward L; Manis T; Carvounis CP
    Ren Fail; 1996 Jan; 18(1):91-6. PubMed ID: 8820505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled trial of spironolactone on carotid intima-media thickness in nondiabetic hemodialysis patients.
    Vukusich A; Kunstmann S; Varela C; Gainza D; Bravo S; Sepulveda D; Cavada G; Michea L; Marusic ET
    Clin J Am Soc Nephrol; 2010 Aug; 5(8):1380-7. PubMed ID: 20522535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FLOW MEDIATED DILATION AND CAROTID INTIMA MEDIA THICKNESS IN PATIENTS WITH CHRONIC GASTRITIS ASSOCIATED WITH HELICOBACTER PYLORI INFECTION.
    Judaki A; Norozi S; Ahmadi MRH; Ghavam SM; Asadollahi K; Rahmani A
    Arq Gastroenterol; 2017 Dec; 54(4):300-304. PubMed ID: 28954039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.